Oxycodone Base
76-42-6
General information
Oxycodone Base is used in Xtampza an extended-release opioid agonist indicated for the management of severe and persistent pain requiring around-the-clock, long-term, daily treatment when alternative treatment options are inadequate.
Trade names
Xtampza IR and Xtampza ER
About the API
Therapeutic areas
Analgesic
Monographs
USP
Regulatory documentation
USDMF
DEA schedule
II
Available grades
Milled
Production location
Wilmington
Standard pack size
20kg
Physical properties
White powder
Typical formulation types
Oral solid